Crinetics director granted RSUs and stock options
Crinetics Pharmaceuticals director Nichols Weston received new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Crinetics Pharmaceuticals director Nichols Weston received new equity awards. The filing shows a grant of 5,925 shares of common stock in the form of restricted stock units, bringing his direct common share holdings to 22,225. He was also granted a stock option over 9,730 shares of common stock at an exercise price of $35.87 per share, expiring on June 18, 2036. Both the restricted stock units and the option vest 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual meeting of stockholders, subject to his continued service on the board.
Insider Trade Summary
Grant/Award: 15,655 shares
Grant/Award
2 txns
Insider
Nichols Weston
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,730 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,925 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,730 contracts (Direct);
Common Stock — 22,225 shares (Direct)
Footnotes (2)
- F1. The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- F2. The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Restricted stock units granted: 5,925 shares
Common shares held after grant: 22,225 shares
Stock option grant size: 9,730 shares
+2 more
5 metrics
Restricted stock units granted
5,925 shares
RSU grant to director on June 18, 2026
Common shares held after grant
22,225 shares
Director’s direct holdings after RSU award
Stock option grant size
9,730 shares
New option covering common stock
Option exercise price
$35.87 per share
Strike price for new stock option
Option expiration date
June 18, 2036
Final expiration of granted stock option
Key Terms
restricted stock units, stock option, vest, annual meeting of the Issuer's stockholders
4 terms
restricted stock units financial
"involves the receipt of restricted stock units, which represent the right to receive shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"The stock option shall vest and become exercisable on the earlier of"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"100% vesting on the earlier of (a) the first anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of the Issuer's stockholders financial
"the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Nichols Weston receive from Crinetics (CRNX)?
Nichols Weston received 5,925 restricted stock units and a stock option over 9,730 shares of Crinetics common stock. These awards represent compensation for his service as a director rather than open-market purchases.
What is the exercise price of Nichols Weston’s new Crinetics stock options?
The new stock option granted to Nichols Weston has an exercise price of $35.87 per share. It covers 9,730 underlying shares of Crinetics common stock and expires on June 18, 2036, if not earlier exercised or forfeited.
When do Nichols Weston’s restricted stock units and options in CRNX vest?
Both the 5,925 restricted stock units and the 9,730-share stock option vest 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual stockholder meeting, assuming he continues serving on the board through vesting.
Are Nichols Weston’s new CRNX awards open-market buys or compensation grants?
The reported transactions are compensation-related grants, not open-market buys. They consist of restricted stock units and a stock option award, both granted at no cash cost to him and vesting based on continued board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates